Single-use Bioprocessing Probes And Sensors Market Current And Future Market Conditions 2021-2028: Grand View Research Inc.

 Single-use Bioprocessing Probes And Sensors Market Growth & Trends

The global single-use bioprocessing probes and sensors market size is expected to reach USD 5.4 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 13.9% from 2021 to 2028. The biopharmaceutical industry is witnessing an increase in the use of single-use technology for the production of biologics, biosimilar, and other biopharmaceutical products. As the need to reduce manufacturing costs is increasing, manufacturers are adopting the implementation of single-use equipment in their production workflow, in turn, boosting revenue growth.

Rising demand for improved bioprocess monitoring devices is another factor driving the market for single-use probes and sensors. Growing biopharmaceutical sector demands advanced sensors to cope with the regulatory norms that require increasingly detailed and complex measurement of processes. Thus, the demand for improved sensors that offer better results is also increasing.

Expanding usage of disposable systems has resulted in lucrative growth for operating players. Key players are making focused efforts to boost their business presence. OEMs are collaborating with independent single-use suppliers to fill the technological gap. Some key OEMs are integrating disposable sensors in their equipment used for various applications, thereby accelerating the adoption of products in this space.

Request a free sample copy or view report summary: Single-use Bioprocessing Probes And Sensors Market Report

Single-use Bioprocessing Probes And Sensors Market Report Highlights

• Single-use pH and dissolved oxygen sensors are the most used disposable sensors in the bioprocessing industry. Products for pressure measurement have already become widely accepted and adopted
• In 2020, the pH sensor segment accounted for the major revenue share as these sensors can be deployed in nearly all the biological processes
• Single-use Dissolved Oxygen (DO) and pH sensors are being used in upstream applications, leading to the large revenue share of the segment
• Increasing application of disposable bioreactors in upstream biopharmaceutical production has driven the use of sensors in this segment
• In addition, the availability of various single-use systems for upstream bioprocessing further supplements segment growth
• Biopharmaceutical manufacturers have emerged as the key end-user of this market
• Increasing adoption of single-use technologies by CMOs is one of the key drivers for the growth of the biopharmaceutical manufacturer segment
• Geographically, North America dominated the market in 2020 owing to the presence of biopharmaceutical clusters and proactiveness of operating end-users in adopting new technologies
• Asia Pacific is expected to be the fastest-growing market over the forecast period, owing to the expanding biomanufacturing capabilities in Asian countries
• The key players are engaged in collaboration with therapy developers to support their product development process

Access Press Release@ https://www.grandviewresearch.com/press-release/global-single-use-bioprocessing-probes-sensors-market

Single-use Bioprocessing Probes And Sensors Market Segmentation

Grand View Research has segmented the global single-use bioprocessing probes and sensors market on the basis of sensor type, workflow, end use, and region:

Single-use Bioprocessing Probes And Sensor Type Outlook (Revenue, USD Million, 2018 - 2028)

• pH Sensor
• Oxygen Sensor
• Pressure Sensors
• Temperature Sensors
• Conductivity Sensors
• Flow Meters & Sensors
• Others

Single-use Bioprocessing Probes And Sensors Workflow Outlook (Revenue, USD Million, 2018 - 2028)

• Upstream
• Downstream

Single-use Bioprocessing Probes And Sensors End-use Outlook (Revenue, USD Million, 2018 - 2028)

• Biopharmaceutical Manufacturer
  • CMOs & CROs
  • In-house Manufacturer
• Labs & Academic/ Clinical Research Institutes

Single-use Bioprocessing Probes And Sensors Regional Outlook (Revenue, USD Million, 2018 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
• Middle East Africa (MEA)
  • South Africa
  • Saudi Arabia

List of Key Players of Single-use Bioprocessing Probes And Sensors Market

• Thermo Fisher Scientific
• Sartorius AG
• Danaher Corporation
• PreSens Precision Sensing GmbH
• ABEC
• Hamilton Company
• PendoTECH LLC
• Equflow
• Parker Hannifin Corporation
• Malema Engineering Corporation
• Dover Corporation
• Broadley-James Corporation
• High Purity New England, Inc.
• Cole-Parmer Instrument Company, LLC.
• ESI Ultrapure

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Intelligent Transportation System Market Strong Application and Emerging Trends also Scope by 2028: Grand View Research Inc.

 Intelligent Transportation System Market Growth & Trends

The global intelligent transportation system market size is expected to reach USD 42,936.1 million by 2028, registering a CAGR of 7.0% from 2021 to 2028, according to a new study by Grand View Research, Inc. Continued advances in the development of transportation networks have triggered the need for an efficient transportation system. At the same time, advances in the latest technologies, such as blind-spot detection and electronic toll collection, are continuously redefining the expectations and prospects for sustainable management of transportation networks and traffic. At this juncture, the growing need to present real-time traffic information to drivers and passengers is emerging as one of the key factors driving the demand for intelligent transportation system (ITS).

Advances in telecommunications technologies and the evolution of IT systems are expected to help in reducing traffic congestions. Given that modern traffic control strategies focus more on utilizing real-time data while simultaneously addressing impact criteria, such as emission control; the integration of ITS with smart grid and other energy distribution and charging systems can potentially help distribution agencies in utilizing the real-time data to draft capacity expansion strategies for the future. According to the ITS Development Strategy drafted by the Department of Transport of the Republic of Korea, intelligent transportation systems can help significantly in reducing traffic congestion, preventing automobile idling, and subsequently in reducing fuel consumption and hence greenhouse gas emissions.

The growing volumes of data involved in transportation management are driving the need for more sophisticated data processing solutions. As such, intelligent transportation systems are leveraging AI to track data in real-time and optimize efficiency. International Business Machine’s Watson is an example of the implementation of artificial intelligence (AI) in transportation management to identify damages to logistics assets leveraging cognitive visual recognition capabilities and to manage the network and optimize routes leveraging predictive analysis.

Request a free sample copy or view report summary: Intelligent Transportation System Market Report

Intelligent Transportation System Market Report Highlights

• The Advanced Traveler Information System (ATMS) segment is anticipated to register considerable growth over the forecast period. ATMS provides traffic management solutions that can potentially improve road safety while enhancing traffic flows and mobility. Traffic management solutions offer real-time data that can help in analyzing and responding to emergencies immediately
• The traffic management segment accounted for the largest market share of over 30% in 2020 and is expected to continue dominating the market over the forecast period. The increase in travel time and hence the fuel consumption and the subsequent monetary losses stemming from traffic congestions are driving the necessity for implementing efficient traffic management systems. Traffic management systems also help in enhancing the operational performance and reliability of road networks
• The North America regional market is anticipated to reach USD 16.13 billion by 2028. The regional market is expected to continue dominating the global market over the forecast period leveraging the advances in telecommunications technology and the aggressive investments in research and development, deployment, and adoption of intelligent transportation systems across the U.S.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-intelligent-transportation-systems-its-market

Intelligent Transportation System Market Segmentation

Grand View Research has segmented the global intelligent transportation system market based on type, application, and region:

Intelligent Transportation System Type Outlook (Revenue, USD Million, 2018 - 2028)

• Advanced Traveler Information System (ATIS)
• Advanced Traffic Management System (ATMS)
• Advanced Transportation Pricing System (ATPS)
• Advanced Public Transportation System (APTS)
• Emergency Medical System (EMS)

Intelligent Transportation System Application Outlook (Revenue, USD Million, 2018 - 2028)

• Traffic Management
• Road Safety and Security
• Freight Management
• Public Transport
• Environment Protection
• Automotive Telematics
• Parking Management
• Road Tolling Systems

Intelligent Transportation System Regional Outlook (Revenue, USD Million, 2018 - 2028)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK.
  • France
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
• South America
  • Brazil
  • Argentina
• MEA
  • UAE
  • KSA

List of Key Players of Intelligent Transportation System Market

• Addco
• Agero, Inc.
• DENSO CORPORATION
• EFKON GmbH
• Hitachi, Ltd.
• Garmin Ltd.
• Thales Group
• Xerox Corporation
• Recardo
• Sensys Networks, Inc.
• Telenav, Inc.
• Iteris, Inc.
• Kapsch TrafficCom
• Lanner
• Nuance Communications, Inc.
• Q-Free ASA
• Siemens AG
• TomTom International BV
• TransCore

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Workflow Management System Market Size Is Expected To Reach USD 55.35 Billion by 2028

 Workflow Management System Market Growth & Trends

The global workflow management system market size is expected to reach USD 55.35 billion by 2028, registering a CAGR of 30.6% from 2021 to 2028, according to a study conducted by Grand View Research, Inc. The rising need for modernizing business processes along with the continued adoption of the latest technologies across various industries such as BFSI, healthcare, retail, IT and telecom, and transportation is anticipated to boost the demand for workflow management systems from 2021 to 2028. Workflow automation helps businesses in automating their daily processes and tasks, reducing human errors, and subsequently augmenting the revenues.

Further, the growing demand for enhanced and efficient operational solutions, which is leading to an increase in sophistication of solutions and services, is anticipated to drive the demand for workflow management systems. Furthermore, advantages offered by the systems, such as real-time tracking, less energy consumption, integrated processes, and data center consolidation, are estimated to drive the market growth. Organizations across the globe are focusing on increasing their business operations as they want to cater to the larger market, hence driving the need for workflow management systems.

The growing trend of remote working and collaborative approaches has resulted in an increased demand for solutions such as remote-ready workflow management and COVID-19 assessment tracker. The market players are trying to exploit this opportunity by offering tracking software and remote-ready workflow management systems as a part of their efforts to increase their customer base. For instance, in April 2020, Kissflow, a provider of workflow and business process management software, announced the launch of a COVID-19 self-assessment tracker app. This app enables organizations to check their employees periodically for COVID-19 symptoms. It also sends employees a list of risk assessment questions (suggested by the CDC (U.S.)) that helps determine an individual’s symptoms and identify appropriate medical care. Furthermore, during the same time, the company also announced the launch of the Remote Work Readiness Survey app, which helped organizations understand the feasibility of allowing employees to work remotely.

The rising adoption of automation and process management solutions across North America is expected to drive the growth of the regional market. Aggressive investments in information technology, a strong emphasis on digital transformation, and a growing preference for cloud technology across the region, particularly in Canada and the U.S., are also expected to contribute to the growth of the regional market over the forecast period.

Request a free sample copy or view report summary: Workflow Management System Market Report

Workflow Management System Market Report Highlights

• The software segment is anticipated register the fastest growth over the forecast period. This is owing to as companies continue to grow, the nature of their business is transforming and companies handling larger volumes of data and additional functionalities
• The cloud segment is anticipated to be fastest-growing market from 2021 to 2028. The preference for cloud deployment is growing as cloud deployment offers flexibility, real-time software updates, and work-from-anywhere capabilities, among other benefits
• The IT and telecom segment is anticipated to be fastest-growing market from 2021 to 2028. Telecom workflow management systems can potentially make the conventional IT and telecom systems extensible and flexible by assisting in accurately managing, tracking, and reporting all IT and software assets, including mobile and fixed telecom assets. Hence, the IT and telecom segment is anticipated to exhibit substantial growth over the forecast period
• Some of the prominent participants in the industry are International Business Machines Corporation; Newgen Software Technologies Limited; Nintex UK Ltd.; Oracle Corporation; Appian; Pegasystems Inc.; Xerox Corporation; and Software AG

Access Press Release@ https://www.grandviewresearch.com/press-release/global-workflow-management-systems-market

Workflow Management System Market Segmentation

Grand View Research has segmented the global workflow management system market based on component, software, service, deployment, vertical, and region:

Workflow Management System Component Outlook (Revenue, USD Million, 2018 - 2028)

• Software
• Service

Workflow Management System Software Outlook (Revenue, USD Million, 2018 - 2028)

• Production Workflow Systems
• Messaging-based Workflow Systems
• Web-based Workflow Systems
• Suite-based Workflow Systems
• Others

Workflow Management System Service Outlook (Revenue, USD Million, 2018 - 2028)

• Consulting
• Integration
• Training & Development

Workflow Management System Deployment Outlook (Revenue, USD Million, 2018 - 2028)

• Cloud
• On-Premise

Workflow Management System Vertical Outlook (Revenue, USD Million, 2018 - 2028)

• BFSI
• Healthcare
• Retail
• IT & Telecom
• Transportation
• Others

Workflow Management System Regional Outlook (Revenue, USD Million, 2018 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
• Asia Pacific
  • China
  • India
  • Japan
• Latin America
  • Brazil
  • Mexico
• Middle East and Africa

List of Key Players of the Workflow Management System Market

• International Business Machines Corporation
• Newgen Software Technologies Limited
• Nintex UK Ltd.
• Oracle Corporation
• Appian
• Pegasystems Inc.
• Xerox Corporation
• Software AG

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Automated Test Equipment Market Expected to Witness a Sustainable Growth over 2028: Grand View Research Inc.

 Automated Test Equipment Market Growth & Trends

The global automated test equipment market size is expected to reach USD 8.94 billion by 2028, according to a new study by Grand View Research, Inc. It is expected to expand at a CAGR of 3.3% from 2021 to 2028. Increasing adoption of System on Chip (SoC) coupled with high demand for consumer electronics is anticipated to drive the growth. Growing electronic content in automotive sector and penetration of smartphones is expected to drive the market. Furthermore, the demand for Automated Test Equipment (ATE) in manufacturing industry as the test equipment save the manufacturing cost and helps in eliminating the defective devices is projected to continue fueling the market.

Miniaturization has spurred demand across various semiconductor manufacturing companies. Additionally, considerable technological advancements coupled with design complexity and the need for adequate testing is expected to positively impact the growth. Developments in semiconductor manufacturing processes along with expansion of wireless networks in developing nations is expected to provide significant growth opportunities for the global market.

The growth of ATE market is primarily driven by semiconductor manufacturing companies which focus on cost-effective testing. Semiconductor manufacturing companies no longer consider fabrication costs as a factor for profit margin in semiconductor chip manufacturing. Semiconductor companies focus on improving their fabrication technology and look for efficient ways of testing to reduce losses due to damages. Advancements in smartphones, tablets, and SoC-based products is creating demand for greater functionality in ATE. As connected devices get smaller, more powerful, and multifaceted; they face design, application, and fabrication challenges, increasing the product demand.

Increasing design complexities along with major technological inventions such as advanced Design for Test (DFT) and adaptive testing are some of the key factors driving the automatic test equipment market. Moreover, recent innovations in Internet of Things (IoT) devices, autonomous vehicles, along with significant changes in the defense and aerospace sectors have significantly transformed the market dynamics.

Non-memory automated test equipment product segment is expected to hold significant market share over the forecast period owing to the increasing number of microcontroller-based applications and demand of the automotive sector. Revenue from IT and telecommunications sector is projected to witness significant growth in the forthcoming years. Asia Pacific accounted for the largest market share in 2019 and is expected to register the fastest growth over the forecast period, owing to the rising number of semiconductor industries in the region. Key market players include Aemulus Holdings Bhd (“Aemulus”); Chroma ATE Inc.; and Teradyne Inc.

Request a free sample copy or view report summary: Automated Test Equipment Market Report

Automated Test Equipment Market Report Highlights

• The growth of automated test equipment market is driven by the significant use of the test equipment in automotive and semiconductor industry
• In the product segment, Non-memory ATE held the largest market share in 2019 and is estimated to witness the second-fastest growth over the forecast period owing to the expansion of consumer electronics, growing number of microcontroller-based application, and other such factors
• In the vertical segment, IT and telecommunication is estimated to continue holding the largest market share in the forthcoming years, owing to the increased focus on effective communication
• The automotive segment is expected to witness considerable growth over the forecast period owing to the increasing integration of the electronic devices in the automobile industry
• North America is estimated to witness substantial growth over the forecast period owing to the high investment in aerospace and defense couple with technological innovations
• Key market players include Aemulus Holdings Bhd (“Aemulus”); Chroma ATE Inc.; Aeroflex Inc. (a subsidiary of Cobham plc); Astronics Corporation; Advantest Corporation; LTX-Credence Corporation (Xcerra Corporation); Teradyne Inc.; STAr Technologies Inc. (a subsidiary of Innotech Corporation); Tesec Corporation; Roos Instruments, Inc.; Marvin Test Solutions Inc.; and Danaher Corporation. Teradyne Inc.; LTX-Credence Corporation (Xcerra Corporation); and Advantest Corporation dominated majority of global market share

Access Press Release@ https://www.grandviewresearch.com/press-release/global-automated-test-equipment

Automated Test Equipment Market Segmentation

Grand View Research has segmented the global automated test equipment market on the basis of product, vertical, and region:

Automated Test Equipment Product Outlook (Revenue, USD Million, 2017 - 2028)

• Non-Memory ATE
• Memory ATE
• Discrete ATE

Automated Test Equipment Vertical Outlook (Revenue, USD Million, 2017 - 2028)

• Automotive
• Consumer
• Aerospace & Defense
• IT & Telecommunications
• Others

Automated Test Equipment Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • UK.
  • Germany
• Asia Pacific
  • China
  • Japan
  • South Korea
  • Taiwan
  • Thailand
  • Singapore
  • Malaysia
• South America
  • Brazil
• Middle East & Africa

List of Key Players of Automated Test Equipment Market

• Aemulus Holdings Bhd (“Aemulus”)
• Chroma ATE Inc.
• Aeroflex Inc. (a subsidiary of Cobham plc)
• Astronics Corporation
• Advantest Corporation
• LTX-Credence Corporation (Xcerra Corporation)
• Teradyne Inc.
• STAr Technologies Inc. (a subsidiary of Innotech Corporation)
• Tesec Corporation
• Roos Instruments, Inc.
• Marvin Test Solutions Inc.
• Danaher Corporation

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Vitrification Market Expected To Propel Industry Growth By 2027: Grand View Research Inc.

 Vitrification Market Growth & Trends

The global Vitrification Market size is expected to reach USD 20.3 billion by 2027, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 17.7% from 2021 to 2027. Several experiments and investigations have been conducted to prove the efficiency of vitrification over slow freezing, leading to its increased clinical implementation. Currently, most IVF clinics are using this method to freeze the eggs/embryos and deliver a higher success rate to patients, thereby driving the market.

Increasing infertility rates have significantly driven the fertility preservation space. Preserving biospecimens has become a common trend among consumers in order to avoid the subsequent consequences of delayed childbearing. Furthermore, increasing awareness of reproductive health has driven the attention of people towards the freezing of biospecimens. This has created commercial opportunities for players such as Vitrolife and IVF Store that are engaged in offering vitrification solutions for fertility preservation.

The increasing infertility rate is further propelling the demand for products offered in this market. On the other hand, ethical concerns about the preservation of eggs and sperms have hampered the market revenue to a considerable extent. The government and regulatory bodies are working towards addressing the concerns by introducing guidelines on various aspects of fertility preservation space.

Request a free sample copy or view report summary: Vitrification Market Report

Vitrification Market Report Highlights

• Currently, vitrification is primarily preferred for the egg-freezing cycle, due to its high success rate over conventional techniques
• The relatively high upfront cost of embryo freezing, compared to egg freezing, has reduced penetration of this segment as compared to the oocytes segment
• However, with the number of increasing IVF cycles, the oocytes segment is anticipated to be a lucrative option
• On the other hand, although semen preservation has been performed before oocytes preservation, in the fast freezing market, these biospecimens account for a very low share in clinical implementation
• However, a substantial number of researches are being carried out to support the clinical implementation of vitrification under this segment
• Furthermore, the IVF clinics segment dominated the market in 2020 owing to the high usage of rapid cooling devices for oocytes preservation for future IVF procedures
• The biobanks segment is expected to witness considerable growth over the forecast period owing to the increase in the number of individuals seeking fertility preservation services
• Europe is recognized as the leader in Assisted Reproductive Technology (ART) space. This has positively favored the high revenue share of this region in the market in 2020
• Following Europe, North America accounted for the significant revenue share in 2020 owing to the increasing investment in R&D for new vitrification solutions coupled with effective regulatory guidelines to support the fertility preservation arena
• The Asian countries are expected to emerge as the lucrative source of revenue owing to the declining fertility rate in countries coupled with the subsequent increase in demand for vitrification products
• The key companies are engaged in making strategic alliances with other operating players to expand the distribution and market reach of their products

Access Press Release@ https://www.grandviewresearch.com/press-release/global-vitrification-market

Vitrification Market Segmentation

Grand View Research has segmented the global Vitrification Market on the basis of specimen, end-use, region:

Vitrification Specimen Outlook (Revenue, USD Million, 2016 - 2027)

• Oocytes
  • Devices
  • Kits & Consumables
• Embryo
  • Devices
  • Kits & Consumables
• Sperm

Vitrification End-use Outlook (Revenue, USD Million, 2016 - 2027)

• IVF Clinics
• Biobanks

Vitrification Regional Outlook (Revenue, USD Million, 2016 - 2027)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • Spain
  • France
  • Italy
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa

List of Key Players of Vitrification Market

• Vitrolife
• IVF Store LLC
• Frozen Cell
• Cook Medical Inc
• Minitube
• IMV Technologies
• Coopersurgical Fertility And Genomic Solutions
• Fujifilm Irvine Scientific
• Biotech Inc.
• Kitazato Corporation

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Laboratory Supplies Market is likely to touch USD 54.1 Billion by 2028: Grand View Research Inc.

 Laboratory Supplies Market Growth & Trends

The global laboratory supplies market size is expected to reach USD 54.1 billion by 2028, expanding at a CAGR of 7.5%, according to a new report by Grand View Research, Inc. Focus on R&D drives the demand for lab equipment market, thereby boosting the market growth.

In June 2019, the D.O.D’s Defense Logistics Agency settled the bidding process for USD 312.0 million contracts, for lab equipment and supplies. There are instances of huge government spending in the category including White House’s budget of 2020 that provides USD 134.0 billion for federal R&D, including significant investments in R&D facilities and equipment.

Laboratories have emerged as multipurpose research facilities in which various types of testing mechanisms, research analogies, and novel developments are carried out. This has also led to an increase in the demand for lab equipment and supplies market. Furthermore, the trend of research-based studies has been gaining traction over the past decade. This has resulted in the development of new laboratories in academic institutes, thereby boosting the market growth.

Recently, clinical laboratories have also gone through major technological advancements. With intense R&D going in the field of the pathogenesis of diseases and personalized medicine, advanced diagnostics methods and tests are being implemented extensively. Technological improvements in instrumentation continue to bring real benefits that accrue from greater ease of use, increased capacity, speed of analysis, higher precision, operational efficiencies, enhanced reliability, improved safety, and numerous other intangibles.

Request a free sample copy or view report summary: Laboratory Supplies Market Report

Laboratory Supplies Market Report Highlights

• Equipment segment dominated the market with a share of 63.0% in 2019 due to the high cost associated with them
• The disposables segment is anticipated to witness a rapid growth rate of 7.7% over the forecast period as they help in avoiding contamination and reducing errors in the procedures
• Among disposables, the tube segment accounted for a maximum share of 19.3% in 2019. They are mostly used in laboratories to view, store, and transport samples
• North America was the leading segment in terms of revenue and market share in 2019. It accounted for 37.0% of the market share in 2019 due to the increasing research activities being carried out in the region.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-laboratory-supply-market

Laboratory Supplies Market Segmentation

Grand View Research has segmented the global laboratory supplies market based on product and region

Laboratory Supplies Product Outlook (Volume, Units; Revenue, USD Million, 2016 - 2028)

• Equipment
  • Incubators
  • Laminar flow hood
  • Micro manipulation systems
  • Centrifuges
  • Lab air filtration system
  • Scopes
  • Sonicators and homogenizers
  • Autoclaves and sterilizers
  • Spectrophotometer and microarray equipment
  • Others
• Disposables
  • Pipettes
  • Tips
  • Tubes
  • Cuvettes
  • Dishes
  • Gloves
  • Masks
  • Cell imaging consumables
  • Cell culture consumables

Laboratory Supplies Regional Outlook (Volume, Units; Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Spain
  • Italy
• Asia Pacific
  • India
  • Japan
  • China
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Laboratory Supplies Market

• Agilent Technologies Inc.
• Danaher Corporation
• Bio-Rad Laboratories, Inc.
• Bruker Corporation
• Fujifilm Holdings Corporation (Irvine Scientific Sales Company, Inc.)
• PerkinElmer Inc.
• Shimadzu Corporation
• Thermo Fisher Scientific, Inc.
• Waters Corporation

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Regulatory Affairs Market Overview, Analysis And Forecast To 2028: Grand View Research Inc.

 Regulatory Affairs Market Growth & Trends

The global regulatory affairs market size is expected to reach USD 22.7 billion by 2028 registering a CAGR of 8.4%, according to a new report by Grand View Research, Inc. Rise in drug approvals, label expansions of approved products, along with the presence of Fastrack regulatory pathways are anticipated to facilitate the market growth over the forecast period. Technological advancements in regulatory software and the growing digital transformation in the healthcare industry are also expected to contribute to market growth. In addition, the introduction of Medical Devices Regulation (MDR) and In Vitro Diagnostics Regulation (IVDR) is anticipated to not only change the EU regulatory landscape and increase the stringency of regulations but also increase the number of documents required to be created and maintained by companies.

Furthermore, the changes in the Central Administration for Pharmaceutical Affairs (CAPA) scope in Egypt is anticipated to change the medical device registration process in the country. Such changes in local regulations are anticipated to favor market growth. Furthermore, several regulatory changes related to clinical trials, vaccine development, and product approvals, initiated by the global and local regulatory authorities to expedite patient access to Covid-19 treatments and vaccines, are anticipated to positively affect the market growth. Market players are actively involved in the adoption of advanced technologies, strategic collaborations, and mergers & acquisition, to strengthen their market positions and outperform the competition. For instance, in 2020, ICON acquired MedPass, a medical device CRO, reimbursement, and regulatory consultancy firm. This acquisition is aimed at strengthening the medical device and diagnostic research services portfolio of ICON through the addition of new clinical and regulatory capabilities in Europe.

Request a free sample copy or view report summary: Regulatory Affairs Market Report

Regulatory Affairs Market Report Highlights

• Regulatory writing and publishing was the leading service segment in 2019 and is projected to retain its dominant position throughout the forecast years
• This growth is credited to an increase in the outsourcing of selected regulatory functions by major life sciences companies
• The Biologicssegment is anticipated to witness the fastest CAGR over the forecast period due to the increasing popularity of personalized medicines and biosimilars
• The oncology indication segment dominated the market in 2019 and will expand further at a steady CAGR from 2020 to 2027
• This growth can be attributed to the rising cancer cases and mortality rate along with the presence of several innovative pipeline products

Access Press Release@ https://www.grandviewresearch.com/press-release/global-regulatory-affairs-market

Regulatory Affairs Market Segmentation

Grand View Research has segmented the global regulatory affairs market on the basis of service, service provider, company size, categories, product stage, indication, end-use, and region:

Regulatory Affairs Service Outlook (Revenue, USD Million, 2016 - 2028)

• Regulatory Consulting
• Legal Representation
• Regulatory Writing & Publishing
• Product Registration & Clinical Trial Application
• Other Services

Regulatory Affairs Service Provider Outlook (Revenue, USD Million, 2016 - 2028)

• In-house
• Outsourcing

Regulatory Affairs Company Size Outlook (Revenue, USD Million, 2016 - 2028)

• Small
• Medium
• Large

Regulatory Affairs Categories Outlook (Revenue, USD Million, 2016 - 2028)

• Drugs
  • Innovator
    • Preclinical
    • Clinical
    • Post Market
  • Generic
    • Preclinical
    • Clinical
    • Post Market
  • Biologics
    • Biotech
      • Preclinical
      • Clinical
      • Post Market
    • ATMP
      • Preclinical
      • Clinical
      • Post Market
    • Biosimilar
      • Preclinical
      • Clinical
      • Post Market
    • Medical Devices
      • Diagnostic
        • Preclinical
        • Clinical
        • Post Market
      • Therapeutic
        • Preclinical
        • Clinical
        • Post Market

Regulatory Affairs Product Stage Outlook (Revenue, USD Million, 2016 - 2028)

• Preclinical
• Clinical
• PMA

Regulatory Affairs Indication Outlook (Revenue, USD Million, 2016 - 2028)

• Oncology
• Neurology
• Cardiology
• Immunology
• Others

Regulatory Affairs End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Medical Device Companies
• Pharmaceutical Companies
• Biotechnology Companies

Regulatory Affairs Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Turkey
  • The Netherlands
  • Switzerland
  • Sweden
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Indonesia
  • Malaysia
  • Singapore
  • Thailand
  • Taiwan
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
• MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Israel

List of Key Players of Regulatory Affairs Market

• Accell Clinical Research, LLC.
• GenPact Ltd.
• Criterium, Inc.
• PRA Health Sciences
• Promedica International
• WuXi AppTec, Inc.
• Medpace
• Charles River Laboratories International, Inc.
• Icon plc
• Covance
• Parexel International Corporation
• Freyr

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Chemiluminescence Immunoassay Market Significant Profits Estimated to be Generated by 2028: Grand View Research Inc.

 Chemiluminescence Immunoassay Market Growth & Trends

The global chemiluminescence immunoassay market size is expected to reach USD 13.75 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 7.9% from 2021 to 2028. The high prevalence of chronic diseases, several advantages of chemiluminescence immunoassay (CLIA) technique, and approval and launch of novel CLIA solutions are anticipated to be the major factors driving the market.

Key players in the market are implementing organic and inorganic growth strategies for the development, launch, and distribution of novel CLIA solutions. For instance, in February 2020, Snibe Diagnostic, a China-based immunoassay manufacturer, received CE marking for its new MAGLUMI 2019-nCoV (SARS-CoV-2) IgM/IgG CLIA kits. In another instance, in January 2018, DiaSorin partnered with Germany-based Qiagen and added Qiagen’s QuantiFERON-TB diagnostic test portfolio to its LIAISON family of fully automated chemiluminescence immunoassay analyzers. Such initiatives by major players are anticipated to significantly support the market growth. However, the high setup cost of automated chemiluminescence immunoassay systems is expected to be a major factor hindering the market growth.

Furthermore, the high prevalence of chronic diseases in key regions and increasing awareness regarding these diseases in emerging economies are anticipated to upsurge the demand for novel diagnostic solutions, including chemiluminescence immunoassay. According to the data published by the American Cancer Society, in 2020, an estimated 1.8 million new cases of cancer were diagnosed in the U.S. and around 606,520 people died due to the disease. In addition, as per the data published by the WHO in November 2020, HIV emerged as a major global public health issue and around 37.9 million people around the globe were living with the disease.

Request a free sample copy or view report summary: Chemiluminescence Immunoassay Market Report

Chemiluminescence Immunoassay Market Report Highlights

• Based on product, consumables dominated the market in 2020 owing to their high demand in therapeutic drug monitoring, endocrinology, and disease diagnosis
• In terms of application, the infectious disease segment held the largest share in 2020 owing to the high prevalence of such diseases and the launch of novel CLIA assays for infectious disease diagnosis
• By end use, in 2020, the hospitals segment accounted for the largest share in 2020 owing to the increasing hospitalizations, along with the rising prevalence of chronic diseases
• In North America, the U.S. held the largest share in 2020 owing to the developed healthcare infrastructure, the high adoption of technologically advanced CLIA systems, and the strong geographical presence of prominent players
• Asia Pacific is expected to expand at the fastest CAGR during the forecast period. The emergence of local players in developing markets, such as India and China, is primarily driving the regional market

Access Press Release@ https://www.grandviewresearch.com/press-release/global-chemiluminescence-immunoassay-market

Chemiluminescence Immunoassay Market Segmentation

Grand View Research has segmented the global chemiluminescence immunoassay market on the basis of product, application, end-use, and region:

Chemiluminescence Immunoassay Product Outlook (Revenue, USD Million, 2016 - 2028)

• Instruments
  • Automated
  • Semi-automated
• Consumables
• Software & Services

Chemiluminescence Immunoassay Application Outlook (Revenue, USD Million, 2016 - 2028)

• Therapeutic Drug Monitoring
• Oncology
• Cardiology
• Endocrinology
• Infectious Disease
• Autoimmune Disease
• Others

Chemiluminescence Immunoassay End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals
• Clinical Laboratories
• Pharmaceutical & Biotechnology Companies
• Others

Chemiluminescence Immunoassay Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • Spain
  • France
  • Italy
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Singapore
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Chemiluminescence Immunoassay Market

• DiaSorin S.p.A.
• Abbott Laboratories
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• Immunodiagnostic Systems
• Siemens Healthineers
• Beckman Coulter Inc.
• Hoffmann-La Roche AG
• Inova Diagnostics, Inc.
• Maccura Biotechnology Co., Ltd.
• Ortho Clinical Diagnostics

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Pharmaceutical Manufacturing Market Trends Regulations And Competitive Landscape Outlook to 2028

 Pharmaceutical Manufacturing Market Growth & Trends

The global pharmaceutical manufacturing market size is expected to reach USD 957.59 billion by 2028, registering a CAGR of 11.34% over the forecast years, according to a new report by Grand View Research, Inc. The presence of supportive regulatory legislations, patentability norms, and high funding and investments in the pharmaceutical industry are anticipated to drive market growth. In addition, the broadening of preventive care has created significant opportunities in the market.

The high burden of diseases, economic growth leading to a rise in disposable incomes, improvements in healthcare infrastructure, better healthcare financing, and a rise in the geriatric population have spurred the demand for pharmaceutical manufacturing techniques in biotechnology and pharmaceutical companies. These factors have also prompted many individuals to use medications to improve their quality of life and wellness. In addition, the emergence of new pandemics, viruses, and drug-resistant infections has provided potential avenues for pharmaceutical manufacturers to accelerate their drug production.

Several drug developers have shifted their preferences towards continuous manufacturing approaches to minimize production costs, overcome medicine shortages, and improve efficiencies. For instance, in March 2021, CONTINUUS Pharmaceuticals announced the construction of the first GMP facility using continuous manufacturing equipment. The company has received a contract from the U.S. government for the production of finished dosage forms and critical APIs. North America accounted for the highest revenue share in 2029 as the U.S. market represents the largest pharmaceutical industry with a substantial number of drug manufacturers.

Request a free sample copy or view report summary: Pharmaceutical Manufacturing Market Report

Pharmaceutical Manufacturing Market Report Highlights

• Conventional drug manufacturing captured a significant revenue share in 2020 owing to the high penetration of small molecules in terms of usage. An increasing number of regulatory approvals has also positively impacted the segment growth
• Outsource drug development accounted for the largest revenue share in 2020 due to continuous efforts undertaken by the key service providers to expand their production capacities
• The Over-the-Counter (OTC) medicines segment is anticipated to grow at the fastest CAGR from 2021 to 2028 due to the continuous transition from prescription to OTC. This shift from prescription medicines to OTC medicines has potentially benefitted the patients both financially and in terms of better health
• The children & adolescents segment is expected to grow at the fastest CAGR from 2021 to 2028 due to the presence of supportive government initiatives that encourage pediatric studies. The Pediatric Research Equity Act and Best Practices for Children Act are among the few initiatives of the FDA that focus on the development of drugs for children
• The retail sale channel segment held the maximum revenue share as a large percentage of individuals use a retail pharmacy as their one-stop-shop for pharmaceutical products

Access Press Release@ https://www.grandviewresearch.com/press-release/global-pharmaceutical-manufacturing-market

Pharmaceutical Manufacturing Market Segmentation

Grand View Research has segmented the global pharmaceutical manufacturing market on the basis of molecule type, drug development type, formulation, routes of administration, therapy area, prescription, age group, sales channel, and region:

Pharmaceutical Manufacturing Molecule Type Outlook (Revenue, USD Billion, 2018 - 2028)

• Biologics & Biosimilars (Large Molecules)
• Conventional Drugs (Small Molecules)

Pharmaceutical Manufacturing Drug Development Type Outlook (Revenue, USD Billion, 2018 - 2028)

• In-house
• Outsource

Pharmaceutical Manufacturing Formulation Outlook (Revenue, USD Billion, 2018 - 2028)

• Tablets
• Capsules
• Injectable
• Sprays
• Suspensions
• Powders
• Other Formulations

Pharmaceutical Manufacturing Routes of Administration Outlook (Revenue, USD Billion, 2018 - 2028)

• Oral
• Topical
• Parenteral
• Inhalations
• Other Routes of Administration

Pharmaceutical Manufacturing Therapy Area Outlook (Revenue, USD Billion, 2018 - 2028)

• Cardiovascular Diseases (CVDs)
• Pain
• Diabetes
• Cancer
• Respiratory Diseases
• Other Diseases

Pharmaceutical Manufacturing Prescription Outlook (Revenue, USD Billion, 2018 - 2028)

• Prescription Medicines
• Over-the-counter (OTC) Medicines

Pharmaceutical Manufacturing Age Group Outlook (Revenue, USD Billion, 2018 - 2028)

• Children & Adolescents
• Adults
• Geriatric

Pharmaceutical Manufacturing Sales Channel Outlook (Revenue, USD Billion, 2018 - 2028)

• Retail
• Non-retail

Pharmaceutical Manufacturing Regional Outlook (Revenue, USD Billion, 2018 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Spain
  • Italy
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Brazil
  • Mexico
• Middle East Africa (MEA)
  • South Africa
  • Saudi Arabia

List of Key Players of Pharmaceutical Manufacturing Market

• Hoffmann-La Roche Ltd.
• Novartis AG
• GlaxoSmithKline plc
• Pfizer, Inc.; Merck & Co., Inc.
• AstraZeneca
• Johnson & Johnson
• Sanofi SA
• Eli Lilly and Company
• AbbVie, Inc.
• Sun Pharmaceutical Industries Ltd.
• Novo Nordisk A/S
• Takeda Pharmaceuticals, Inc.
• Cipla Ltd.
• Bristol Myers Squibb Company
• Gilead Sciences, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.